DOBMEIER ERIC 4/A
4/A · Janux Therapeutics, Inc. · Filed Jul 24, 2024
Insider Transaction Report
Form 4/AAmended
DOBMEIER ERIC
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-07-19+4,111→ 4,111 totalExercise: $44.68Exp: 2034-07-18→ Common Stock (4,111 underlying) - Award
Common Stock
2024-07-19+1,231→ 6,231 total
Footnotes (2)
- [F1]Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date.
- [F2]The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date.